Table 2.

Correlation between hepcidin expression and clinicopathological features in TCGA-KIRC patients (n=539)

Characteristics	Odds Ratio (OR)	P value
Age (>60 vs. ≤60)	0.831 (0.592-1.164)	0.282
Gender (Male vs. Female)	1.597 (1.117-2.289)	0.010*
Laterality (Right vs. Left)	0.914 (0.651-1.283)	0.604
T stage (T3 & T4 vs. T1 & T2)	2.053 (1.434-2.954)	<0.001***
N stage (N1 vs. N0)	4.089 (1.279-18.161)	0.031*
M stage (M1 vs. M0)	2.306 (1.396-3.901)	0.001**
Pathologic stage (Stage III & Stage IV vs. Stage I & Stage II)	2.268 (1.591-3.250)	<0.001***
WHO grade (G3 & G4 vs. G1 & G2)	2.300 (1.626-3.266)	<0.001***

^* P<0.05;

^** P<0.01;

^*** P<0.001.